MC

Moturi Chandrasekhar Rao

Director DIN 02183973
DIN 02183973 First appointment Jun 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Moturi Chandrasekhar Rao

Data last updated:

Moturi Chandrasekhar Rao was a Director at Sri Meenakshi Chits (India) Private Limited (from 2011) and Director at Mania Pharma Private Limited (from 2008).

DIN 02183973
First Appointment 20 Jun 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20112011Strike Off
Mania Pharma Private Limited U24233TG2008PTC059751
Director20 Jun 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Meenakshi Chits (India) Private Limited
Mania Pharma Private Limited
Premium access

Shareholding and investment profile for Moturi Chandrasekhar Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Moturi Chandrasekhar Rao

Moturi Chandrasekhar Rao was first appointed on 20 Jun 2008 as Director at Mania Pharma Private Limited. The most recent appointment on record is 28 Apr 2011 at Sri Meenakshi Chits (India) Private Limited.

Moturi Chandrasekhar Rao held 2 earlier board appointments: Sri Meenakshi Chits (India) Private Limited (Director, from 28 Apr 2011); Mania Pharma Private Limited (Director, from 20 Jun 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available